European Deep Brain Stimulation (DBS) Depression Study
This study is ongoing, but not recruiting participants.
Sponsor:
St. Jude Medical
Information provided by (Responsible Party):
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT01331330
First received: April 4, 2011
Last updated: February 26, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate the effects of two different programming settings of deep brain stimulation (DBS) in the subgenual white matter (Brodmann Area 25 WM) as an adjunctive treatment for TR-MDD, single or recurrent episode on mood as measured by the MADRS.
| Condition | Intervention |
|---|---|
|
Depressive Disorder, Major |
Device: Deep Brain Stimulation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Clinical Evaluation of Different Device Parameters for the Management of Patients With Treatment Resistant Major Depressive Disorder, Single or Recurrent Episode, With Deep Brain Stimulation |
Resource links provided by NLM:
Further study details as provided by St. Jude Medical:
Primary Outcome Measures:
- Percentage of change from mean baseline values in MADRS score [ Time Frame: 6 Months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Percentage of change from baseline value of HDRS [ Time Frame: 3, 6, 9, and 12 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 60 |
| Study Start Date: | May 2011 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Group B
Low Programming
|
Device: Deep Brain Stimulation
Low Programming
Other Name: Libra Deep Brain Stimulation System(St. Jude Medical Neuromodulation Division)
|
|
Experimental: Group A
Normal Programming
|
Device: Deep Brain Stimulation
Normal DBS Programming
Other Name: Libra Deep Brain Stimulation System (St. Jude Medical Neuromodulation Division)
|
Eligibility| Ages Eligible for Study: | 21 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Men and women (non-pregnant) age is 21-70 years;
- Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by DSM-IV-TR criteria derived from the MINI;
- First episode onset before age 45;
- Current episode > 12 month duration;
- In the current episode: Documented resistance to a minimum of 4 adequate depression treatments from at least 3 different categories;
- In adult lifetime (>21 year of age) have experience a period of wellness as defined by DSM IV criteria;
- MADRS score ≥22 at 2 separate baseline visits, rated by 2 separate psychiatrists;
- GAF score <50;
- Mini-mental state examination (MMSE) score >24;
- No change in current antidepressant medication regimen or medication free for at least 4 weeks prior to study entry;
- Able to give informed consent in accordance with institutional policies;
Exclusion Criteria:
- A diagnosis of bipolar I or bipolar II disorder by DSM-IV-TR criteria, derived from the MINI;
- Meets criteria for borderline or antisocial personality disorder in the last 12 months by DSM-IV-TR criteria, derived from the Cluster B Personality Disorders Sections 301.7 - 301.83, preferably screened via SCID-II at Baseline visit (optional);
- In the current depressive episode, has been diagnosed with General Anxiety Disorder (GAD) - as defined by the DSM-IV-TR, and GAD is the primary diagnosis;
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01331330
Locations
| Austria | |
| Paracelsus Medical University | |
| Salzburg, Austria, 5020 | |
| France | |
| CHU Pasteur | |
| Nice, France, 06002 | |
| Hôpital La Pitié Salpêtrière | |
| Paris, France, 75651 | |
| Germany | |
| University Hospital | |
| Bonn, Germany, D-53105 | |
| Israel | |
| Hadassah-Hebrew University Medical Center | |
| Jerusalem, Israel, 91120 | |
| United Kingdom | |
| National Hospital for Neurology and Neurosurgery - UCL | |
| London, United Kingdom, WC1N 3 | |
| King's College London | |
| London, United Kingdom, SE5 9RS | |
Sponsors and Collaborators
St. Jude Medical
More Information
No publications provided
| Responsible Party: | St. Jude Medical |
| ClinicalTrials.gov Identifier: | NCT01331330 History of Changes |
| Other Study ID Numbers: | NM-09-035-EU-DB |
| Study First Received: | April 4, 2011 |
| Last Updated: | February 26, 2013 |
| Health Authority: | Israel: Ministry of Health |
Keywords provided by St. Jude Medical:
|
Depressive Disorder Unipolar Implantable Stimulation Electrodes |
Additional relevant MeSH terms:
|
Depressive Disorder Depression Depressive Disorder, Major |
Mood Disorders Mental Disorders Behavioral Symptoms |
ClinicalTrials.gov processed this record on May 22, 2013